Terms: = Sarcomas AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Staging
21 results:
1. Leiomyosarcoma of the urinary bladder: A SEER database study and comparison to leiomyosarcomas of the uterus and extremities/trunk.
Coiner BL; Cates J; Kamanda S; Giannico GA; Gordetsky JB
Ann Diagn Pathol; 2021 Aug; 53():151743. PubMed ID: 33964611
[TBL] [Abstract] [Full Text] [Related]
2. Leiomyosarcoma of the Nasal Cavity.
Saadoun R; Obermueller T; Franke M; Schell A; Mückner K; Riemann R
Ear Nose Throat J; 2022 Jun; 101(5):NP218-NP221. PubMed ID: 32951455
[TBL] [Abstract] [Full Text] [Related]
3. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract] [Full Text] [Related]
4. CT imaging improves histopathological grading of retroperitoneal leiomyosarcomas.
Mcaddy NC; Hallin M; Strauss D; Smith M; Hayes A; Yusuf S; Moskovic E; Fotiadis N; van Houdt W; Jones RL; Gronchi A; Thway K; Messiou C
Eur J Surg Oncol; 2020 Feb; 46(2):288-292. PubMed ID: 31653457
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.
Momtahan M; Emami F; Sari Aslani F; Akbarzadeh-Jahromi M
J Chin Med Assoc; 2020 Jan; 83(1):84-88. PubMed ID: 31517774
[TBL] [Abstract] [Full Text] [Related]
6. Jejunal leiomyosarcoma: Report of a rare case diagnosed on cytology.
Elhence PA; Rao M; Vishnoi JR; Meena V
Diagn Cytopathol; 2019 May; 47(5):498-502. PubMed ID: 30578601
[TBL] [Abstract] [Full Text] [Related]
7. Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
Bélissant O; Champion L; Thevenet H; Weinmann P; Alberini JL
Nucl Med Commun; 2018 Jul; 39(7):652-658. PubMed ID: 29683931
[TBL] [Abstract] [Full Text] [Related]
8. Sarcomatoid Squamous Cell Carcinoma of the Penis - a Report of Two Cases.
Bachurska SY; Antonov PA; Staykov DG; Dechev IY
Folia Med (Plovdiv); 2017 Jun; 59(2):232-237. PubMed ID: 28704194
[TBL] [Abstract] [Full Text] [Related]
9. Impact of adjuvant treatment on oncologic outcomes in patients with stage I leiomyosarcoma of the uterus.
Boyraz G; Başaran D; Salman MC; Özgül N; Yüce K
Turk J Med Sci; 2017 Jun; 47(3):841-846. PubMed ID: 28618731
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
[TBL] [Abstract] [Full Text] [Related]
11. Concurrent occurrence of primary intracranial Epstein-Barr virus-associated leiomyosarcoma and Hodgkin lymphoma in a young adult.
Takei H; Powell S; Rivera A
J Neurosurg; 2013 Aug; 119(2):499-503. PubMed ID: 23621602
[TBL] [Abstract] [Full Text] [Related]
12. Primary and secondary leiomyosarcoma of the oral and perioral region--clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature.
Schütz A; Smeets R; Driemel O; Hakim SG; Kosmehl H; Hanken H; Kolk A
J Oral Maxillofac Surg; 2013 Jun; 71(6):1132-42. PubMed ID: 23434173
[TBL] [Abstract] [Full Text] [Related]
13. Diagnosis and treatment of sarcoma of the uterus. A review.
Tropé CG; Abeler VM; Kristensen GB
Acta Oncol; 2012 Jul; 51(6):694-705. PubMed ID: 22793037
[TBL] [Abstract] [Full Text] [Related]
14. [Acatholytic variant of squamous carcinoma of the breast. A case report and review of literature].
Kajo K; Macháleková K; Kajo M; Zúbor P
Cesk Patol; 2011 Oct; 47(4):184-8. PubMed ID: 22145220
[TBL] [Abstract] [Full Text] [Related]
15. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.
Zivanovic O; Jacks LM; Iasonos A; Leitao MM; Soslow RA; Veras E; Chi DS; Abu-Rustum NR; Barakat RR; Brennan MF; Hensley ML
Cancer; 2012 Feb; 118(3):660-9. PubMed ID: 21751199
[TBL] [Abstract] [Full Text] [Related]
16. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
Zivanovic O; Leitao MM; Iasonos A; Jacks LM; Zhou Q; Abu-Rustum NR; Soslow RA; Juretzka MM; Chi DS; Barakat RR; Brennan MF; Hensley ML
J Clin Oncol; 2009 Apr; 27(12):2066-72. PubMed ID: 19255317
[TBL] [Abstract] [Full Text] [Related]
17. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy following surgery in the management of uterine sarcomas.
Szánthó A; Bálega J; Szabó I; Demeter A; Sipos N; Csapó Z; Papp Z
Eur J Gynaecol Oncol; 2003; 24(5):421-4. PubMed ID: 14584661
[TBL] [Abstract] [Full Text] [Related]
19. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
Rao UN; Finkelstein SD; Jones MW
Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
[TBL] [Abstract] [Full Text] [Related]
20. Adult genitourinary sarcomas: a report of seventeen cases and review of the literature.
Berkmen F; Celebioğlu AS
J Exp Clin Cancer Res; 1997 Mar; 16(1):45-8. PubMed ID: 9148860
[TBL] [Abstract] [Full Text] [Related]
[Next]
